These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 19524661)

  • 1. Comparative analysis of extracellular enzymes and virulence exhibited by Burkholderia pseudomallei from different sources.
    Vellasamy KM; Vasu C; Puthucheary SD; Vadivelu J
    Microb Pathog; 2009 Sep; 47(3):111-7. PubMed ID: 19524661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic profiling of clinical and environmental isolates of Burkholderia pseudomallei.
    Liew SM; Tay ST; Wongratanacheewin S; Puthucheary SD
    Trop Biomed; 2012 Mar; 29(1):160-8. PubMed ID: 22543616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mviN homolog in Burkholderia pseudomallei is essential for viability and virulence.
    Ling JM; Moore RA; Surette MG; Woods DE
    Can J Microbiol; 2006 Sep; 52(9):831-42. PubMed ID: 17110975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular investigation of virulence determinants between a virulent clinical strain and an attenuated strain of Burkholderia pseudomallei.
    Puthucheary SD; Puah SM; Chai HC; Thong KL; Chua KH
    J Mol Microbiol Biotechnol; 2012; 22(3):198-204. PubMed ID: 22846664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
    Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
    Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity and response of Burkholderia pseudomallei and Burkholderia cepacia to insulin.
    Kanai K; Kondo E; Kurata T
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):584-91. PubMed ID: 9185275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence of clinical and environmental isolates of Burkholderia oklahomensis and Burkholderia thailandensis in hamsters and mice.
    Deshazer D
    FEMS Microbiol Lett; 2007 Dec; 277(1):64-9. PubMed ID: 17986086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional redundancy of Burkholderia pseudomallei phospholipase C enzymes and their role in virulence.
    Srinon V; Withatanung P; Chaiwattanarungruengpaisan S; Thongdee M; Meethai C; Stevens JM; Titball RW; Korbsrisate S
    Sci Rep; 2020 Nov; 10(1):19242. PubMed ID: 33159122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease production by Burkholderia pseudomallei and virulence in mice.
    Gauthier YP; Thibault FM; Paucod JC; Vidal DR
    Acta Trop; 2000 Feb; 74(2-3):215-20. PubMed ID: 10674652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.
    Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of two distinct phospholipase C enzymes from Burkholderia pseudomallei.
    Korbsrisate S; Tomaras AP; Damnin S; Ckumdee J; Srinon V; Lengwehasatit I; Vasil ML; Suparak S
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1907-1915. PubMed ID: 17526847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.
    Challacombe JF; Stubben CJ; Klimko CP; Welkos SL; Kern SJ; Bozue JA; Worsham PL; Cote CK; Wolfe DN
    PLoS One; 2014; 9(12):e115951. PubMed ID: 25536074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections.
    van Schaik E; Tom M; DeVinney R; Woods DE
    Microbes Infect; 2008 Oct; 10(12-13):1291-9. PubMed ID: 18707015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
    Kang WT; Vellasamy KM; Chua EG; Vadivelu J
    J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence.
    Pilatz S; Breitbach K; Hein N; Fehlhaber B; Schulze J; Brenneke B; Eberl L; Steinmetz I
    Infect Immun; 2006 Jun; 74(6):3576-86. PubMed ID: 16714590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of sitafloxacin against Burkholderia pseudomallei.
    Thamlikitkul V; Trakulsomboon S
    Int J Antimicrob Agents; 2011 Oct; 38(4):364. PubMed ID: 21775108
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
    Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
    Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei.
    Novak RT; Glass MB; Gee JE; Gal D; Mayo MJ; Currie BJ; Wilkins PP
    J Clin Microbiol; 2006 Jan; 44(1):85-90. PubMed ID: 16390953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-RFLP analysis of the flagellin sequences for identification of Burkholderia pseudomallei and Burkholderia cepacia from clinical isolates.
    Tungpradabkul S; Wajanarogana S; Tunpiboonsak S; Panyim S
    Mol Cell Probes; 1999 Apr; 13(2):99-105. PubMed ID: 10208800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.